PHARMACEUTICAL COMPOSITION CONTAINING SELEGILINE, (N,ALPHA-DIMETHYL-N-2-PROPYNYLBENZENE-ETHANAMINE)

A new stable solid composition suitable for oral administration comprising a pharmaceutically acceptable acid addition salt of selegiline is achieved by reducing the destabilising effect of the conventional lubricant present in such compositions, magnesium stearate, by adding to the selegiline-conta...

Full description

Saved in:
Bibliographic Details
Main Authors LENNART, SEPPO SULEVI, PIIPPO, ILSE MARIA, HALONEN, MATTI AUKUSTI, LEINONEN, ULLA INKERI, ORN, GUNILLA MARGARETA
Format Patent
LanguageEnglish
Published 26.01.1996
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new stable solid composition suitable for oral administration comprising a pharmaceutically acceptable acid addition salt of selegiline is achieved by reducing the destabilising effect of the conventional lubricant present in such compositions, magnesium stearate, by adding to the selegiline-containing tablets, a pharmaceutically acceptable acid having a pKa value below 5.88.
Bibliography:Application Number: NZ19940263568